cerivastatin [orch, phsu]
Review [inpr]
Pharmacological [bmod]
properties [qlco]
Therapeutic Efficacy [qlco]
Management [ocac]
Hypercholesterolaemia [dsyn]
cerivastatin [orch, phsu]
HMG-CoA reductase inhibitor [orch, phsu]
treatment [ftcn]
Patients [podg]
Hypercholesterolaemia [dsyn]
Lipid [lipd]
lowering [spco]
Efficacy [qlco]
cerivastatin [orch, phsu]
Large [qnco]
Clinical Trials [resa]
Early [tmco]
studies [lbpr]
cerivastatin [orch, phsu]
low [qlco]
Dosages [qnco]
Equal [qlco]
Orally [spco]
Daily [tmco]
More [ftcn]
Recent [tmco]
studies [lbpr]
Focused [spco]
Dosages [qnco]
mg day [qnco]
Currently [tmco]
Recommended [idcn]
Food and Drug Administration [hcro]
Improvement [cnce]
Serum [bdsu]
Level [qlco]
Triglycerides [bacs, lipd]
High Density Lipoprotein Cholesterol [bacs, lipd]
cerivastatin [orch, phsu]
mg day [qnco]
Marked [qlco]
reductions [npop]
Serum [bdsu]
Level [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
Total Cholesterol [lbpr]
included [ftcn]
Result [ftcn]
Pivot [medd]
North American [fndg]
Trial [resa]
Patients [podg]
Hypercholesterolaemia [dsyn]
Study [mnob]
national [inpr]
Cholesterol [bacs, strd]
Education [edac]
program treatment [hlca]
Adult [aggp]
Panel [idcn]
Ii [aapp]
Target [ftcn]
Level [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
Patients [podg]
To [qlco]
Receive [qlco]
cerivastatin [orch, phsu]
mg day [qnco]
treated [topp]
cerivastatin [orch, phsu]
mg day [qnco]
placebo [topp]
Recipient [humn]
Patients [podg]
baseline [bodm]
Serum [bdsu]
Low density lipoprotein cholesterol level [lbpr]
Meeting [hlca]
Guidelines [inpr]
Start [tmco]
Pharmacotherapy [topp]
Target [ftcn]
Low density lipoprotein cholesterol level [lbpr]
cerivastatin [orch, phsu]
mg day [qnco]
Patients [podg]
Receive [qlco]
cerivastatin [orch, phsu]
mg day [qnco]
Low density lipoprotein cholesterol level [lbpr]
Reduced [qlco]
Percentile [qnco]
Various [irda]
Clinical Trials [resa]
cerivastatin [orch, phsu]
Greatest [qnco]
Lipid [lipd]
lowering [spco]
Response [orga]
Expected [idcn]
Women [popg]
Elderly [popg]
Patients [podg]
cerivastatin [orch, phsu]
Well [qlco]
adverse events [fndg]
Mild [qlco]
Transient [popg]
Overall [inpr]
Incidence [qnco]
Nature [idcn]
adverse events [fndg]
Reported [inpr]
cerivastatin [orch, phsu]
Clinical Trials [resa]
Similar [qlco]
placebo [topp]
Most [qnco]
Frequent [tmco]
adverse events [fndg]
Associated [qlco]
cerivastatin [orch, phsu]
Headache [sosy]
GI [idcn]
Disturbance [qlco]
Asthenia [sosy]
Pharyngitis [dsyn]
Rhinitis [dsyn]
Large [qnco]
Pivot [medd]
Trial [resa]
elevations [spco]
Serum [bdsu]
Level [qlco]
Creatine Kinase [aapp, enzy]
Transaminases [aapp, enzy]
Reported [inpr]
Small [qnco]
Proportion [qnco]
Patients [podg]
Receive [qlco]
cerivastatin [orch, phsu]
Not [ftcn]
placebo [topp]
Recipient [humn]
HMG-CoA Reductase Inhibitors [orch, phsu]
Rare [tmco]
Reports [inpr]
Myopathy [dsyn]
Rhabdomyolysis [patf]
Occurred [acty]
cerivastatin [orch, phsu]
Gemfibrosil [lipd, phsu]
Ciclosporin [aapp, phsu]
Administered [ftcn]
Cases [ftcn]
surveillance [ftcn]
Study [mnob]
Performed [ftcn]
formulary [inpr]
Switch [mnob]
Conversion [ftcn]
studies [lbpr]
cerivastatin [orch, phsu]
Equivalent [qlco]
Superior [spco]
HMG-CoA Reductase Inhibitors [orch, phsu]
Including [ftcn]
atorvastatin [orch, phsu]
Reducing [qlco]
Serum [bdsu]
Low density lipoprotein cholesterol level [lbpr]
Target [ftcn]
pharmacoeconomic [qnco]
Data [idcn]
cerivastatin [orch, phsu]
Limited [ftcn]
Analysis [lbpr]
Conduct [inbe]
Date [tmco]
Italy [geoa]
Suggest [idcn]
cerivastatin [orch, phsu]
Compare [acty]
Available [ftcn]
HMG-CoA Reductase Inhibitors [orch, phsu]
Cost [qnco]
Life [idcn]
Gain [qnco]
Conclusion [idcn]
cerivastatin [orch, phsu]
Well [qlco]
effective [qlco]
Lipid lowering agent [phsu]
Patients [podg]
Hypercholesterolaemia [dsyn]
GIVEN [cnce]
Dosages [qnco]
Currently [tmco]
Recommended [idcn]
Food and Drug Administration [hcro]
cerivastatin [orch, phsu]
Marked [qlco]
reductions [npop]
Serum [bdsu]
Level [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
Reaching [orgf]
Target [ftcn]
Level [qlco]
majority [socb]
Patients [podg]
cerivastatin [orch, phsu]
Cost Effectiveness [qnco]
Alternative [cnce]
Currently [tmco]
Available [ftcn]
HMG-CoA Reductase Inhibitors [orch, phsu]
First [qnco]
Line [spco]
Agent [chvf]
Hypercholesterolaemia [dsyn]
